Covid-19
U.S. authorizes Moderna COVID-19 vaccine, elderly next in line for shots
By
Moderna Inc’s coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
Millions of doses of the Moderna vaccine are expected to be added to the U.S. rollout, which began this week with healthcare workers. Older people in long-term care facilities are next in line for vaccines, with a U.S. Centers for Disease Control and Prevention expert panel on Sunday set to recommend what groups follow, as industries compete to have their workers given precedence.
The FDA announced the authorization the day after the agency’s panel of outside experts endorsed its use and a week after the FDA authorized a vaccine from Pfizer Inc and German partner BioNTech SE.
The vaccine from Pfizer and BioNTech, based on similar technology, has been put into the arms of thousands of U.S. healthcare workers this week in a massive nationwide rollout. Moderna injections are expected to begin in coming days for adults 18 years old and up.
“With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day,” FDA Commissioner Stephen M. Hahn, M.D, said in a statement.
Moderna Inc’s coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
Millions of doses of the Moderna vaccine are expected to be added to the U.S. rollout, which began this week with healthcare workers. Older people in long-term care facilities are next in line for vaccines, with a U.S. Centers for Disease Control and Prevention expert panel on Sunday set to recommend what groups follow, as industries compete to have their workers given precedence.
The FDA announced the authorization the day after the agency’s panel of outside experts endorsed its use and a week after the FDA authorized a vaccine from Pfizer Inc and German partner BioNTech SE.
The vaccine from Pfizer and BioNTech, based on similar technology, has been put into the arms of thousands of U.S. healthcare workers this week in a massive nationwide rollout. Moderna injections are expected to begin in coming days for adults 18 years old and up.
“With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day,” FDA Commissioner Stephen M. Hahn, M.D, said in a statement.
-
Local News1 week agoTwo people taken to a hospital after a fiery crash on I-94
-
North Dakota1 week agoNorth Dakota has the highest lung cancer treatment rate in the U.S.
-
Local News1 week agoVictim in fatal motorcycle accident identified
-
Local News1 week agoInmate charged after attacking a deputy at Cass County Jail
-
North Dakota1 week agoPublic’s help needed in locating a missing boy
-
Crime & Safety2 weeks agoHandicapped man facing multiple charges following an altercation with Minot police officers
-
Local News2 weeks agoFargo Jet Center flight school added four new planes to its training fleet
-
Crime & Safety2 weeks agoHillsboro man taken into custody on multiple charges after an incident at Subway restaurant